Alerts will be sent to your verified email
Verify Email
TRABI
|
Transgene Biotek
|
Nidan Labs. & Health
|
Chennai Meena Multi
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 5.86 % | 192.36 % |
|
5yr average Equity Multiplier
|
11.14 | 1.8 | 14.31 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.32 | 1.48 |
|
5yr Avg Net Profit Margin
|
-5919.21 % | 5.91 % | 0.7 % |
|
Price to Book
|
2.61 | 0.0 | 0.0 |
|
P/E
|
0.0 | 12.55 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
59.29 Days | -378.19 Days | -60.02 Days |
|
Inventory Days
|
166.26 Days | 3.89 Days | 5.94 Days |
|
Days Receivable
|
11.76 Days | 13.34 Days | 7.53 Days |
|
Days Payable
|
259.7 Days | 205.76 Days | 87.3 Days |
|
5yr Average Interest Coverage Ratio
|
-19.2 | 2.0 | 1.58 |
|
5yr Avg ROCE
|
-3.86 % | 11.91 % | 13.41 % |
|
5yr Avg Operating Profit Margin
|
-527.18 % | 30.14 % | 6.64 % |
|
5 yr average Debt to Equity
|
1.02 | 0.73 | 6.16 |
|
5yr CAGR Net Profit
|
-42.08 % | -2.95 % | 1.85 % |
|
5yr Average Return on Assets
|
-3.77 % | 2.0 % | 1.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.64 % | 57.04 % | 57.1 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.18 % | 1.32 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Transgene Biotek
|
Nidan Labs. & Health
|
Chennai Meena Multi
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|